These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 30010913)

  • 41. The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?
    Patel C; Brotherton JM; Pillsbury A; Jayasinghe S; Donovan B; Macartney K; Marshall H
    Euro Surveill; 2018 Oct; 23(41):. PubMed ID: 30326995
    [TBL] [Abstract][Full Text] [Related]  

  • 42. UK population based study to predict impact of HPV vaccination.
    Hibbitts S; Tristram A; Beer H; McRea J; Rose B; Hauke A; Nuttall D; Dallimore N; Newcombe RG; Fiander A
    J Clin Virol; 2014 Feb; 59(2):109-14. PubMed ID: 24388208
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Urine testing to monitor the impact of HPV vaccination in Bhutan and Rwanda.
    Franceschi S; Chantal Umulisa M; Tshomo U; Gheit T; Baussano I; Tenet V; Tshokey T; Gatera M; Ngabo F; Van Damme P; Snijders PJ; Tommasino M; Vorsters A; Clifford GM
    Int J Cancer; 2016 Aug; 139(3):518-26. PubMed ID: 26991686
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human papillomavirus prevalence and vaccine effectiveness in young women in Germany, 2017/2018: results from a nationwide study.
    Loenenbach A; Schönfeld V; Takla A; Wiese-Posselt M; Marquis A; Thies S; Sand M; Kaufmann AM; Wichmann O; Harder T
    Front Public Health; 2023; 11():1204101. PubMed ID: 37719724
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fall in human papillomavirus prevalence following a national vaccination program.
    Tabrizi SN; Brotherton JM; Kaldor JM; Skinner SR; Cummins E; Liu B; Bateson D; McNamee K; Garefalakis M; Garland SM
    J Infect Dis; 2012 Dec; 206(11):1645-51. PubMed ID: 23087430
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cervical Infection With Vaccine-Associated Human Papillomavirus (HPV) Genotypes as a Predictor of Acquisition and Clearance of Other HPV Infections.
    Tota JE; Ramanakumar AV; Villa LL; Richardson H; Burchell AN; Coutlée F; Franco EL
    J Infect Dis; 2016 Sep; 214(5):676-84. PubMed ID: 27256157
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human papillomavirus types in cervical dysplasia among young HPV-vaccinated women: Population-based nested case-control study.
    Kann H; Hortlund M; Eklund C; Dillner J; Faust H
    Int J Cancer; 2020 May; 146(9):2539-2546. PubMed ID: 31868230
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effectiveness of Human Papillomavirus Vaccination on Prevalence of Vaccine Genotypes in Young Sexually Active Women in France.
    Heard I; Tondeur L; Arowas L; Demazoin M; Falguières M; Parent Du Chatelet I;
    J Infect Dis; 2017 Mar; 215(5):757-763. PubMed ID: 28011911
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of HPV type-replacement in unvaccinated and vaccinated adolescent females-Post-hoc analysis of a community-randomized clinical trial (II).
    Gray P; Palmroth J; Luostarinen T; Apter D; Dubin G; Garnett G; Eriksson T; Natunen K; Merikukka M; Pimenoff V; Söderlund-Strand A; Vänskä S; Paavonen J; Pukkala E; Dillner J; Lehtinen M
    Int J Cancer; 2018 Jun; 142(12):2491-2500. PubMed ID: 29377141
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of human papillomavirus vaccination on racial/ethnic disparities in vaccine-type human papillomavirus prevalence among 14-26 year old females in the U.S.
    Hirth J; McGrath CJ; Kuo YF; Rupp RE; Starkey JM; Berenson AB
    Vaccine; 2018 Nov; 36(50):7682-7688. PubMed ID: 30377066
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence of Human Papillomavirus (HPV) and HPV Type Distribution in Penile Samples in Young Men in Denmark: Results 10 Years After Implementation of a Girls-Only HPV Vaccination Program.
    Munk C; Reinholdt K; Kjaer AK; Hemmingsen CH; Ørnskov D; Iftner T; Waldstrøm M; Kjaer SK
    J Infect Dis; 2024 Oct; 230(4):949-956. PubMed ID: 38470214
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Declines in Prevalence of Human Papillomavirus Vaccine-Type Infection Among Females after Introduction of Vaccine - United States, 2003-2018.
    Rosenblum HG; Lewis RM; Gargano JW; Querec TD; Unger ER; Markowitz LE
    MMWR Morb Mortal Wkly Rep; 2021 Mar; 70(12):415-420. PubMed ID: 33764964
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010.
    Markowitz LE; Hariri S; Lin C; Dunne EF; Steinau M; McQuillan G; Unger ER
    J Infect Dis; 2013 Aug; 208(3):385-93. PubMed ID: 23785124
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vaccine Effectiveness Following Routine Immunization With Bivalent Human Papillomavirus (HPV) Vaccine: Protection Against Incident Genital HPV Infections From a Reduced-Dosing Schedule.
    Hoes J; King AJ; Klooster TMSV; Berkhof J; Bogaards JA; de Melker HE
    J Infect Dis; 2022 Sep; 226(4):634-643. PubMed ID: 33964158
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence of oral human papillomavirus by vaccination status among young adults (18-30years old).
    Hirth JM; Chang M; Resto VA;
    Vaccine; 2017 Jun; 35(27):3446-3451. PubMed ID: 28526331
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessment of herd effects among women and heterosexual men after girls-only HPV16/18 vaccination in the Netherlands: A repeated cross-sectional study.
    Woestenberg PJ; Bogaards JA; King AJ; Leussink S; van der Sande MA; Hoebe CJ; van Benthem BH;
    Int J Cancer; 2019 Jun; 144(11):2718-2727. PubMed ID: 30426502
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Changes in (risk) behavior and HPV knowledge among Dutch girls eligible for HPV vaccination: an observational cohort study.
    Donken R; Tami A; Knol MJ; Lubbers K; van der Sande MAB; Nijman HW; Daemen T; Weijmar Schultz WCM; de Melker HE
    BMC Public Health; 2018 Jul; 18(1):837. PubMed ID: 29976170
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Colposcopic performance in a birth cohort previously eligible for human papillomavirus vaccination.
    Sahlgren HAI; Elfgren K; Sparen P; Elfstrom MK
    Am J Obstet Gynecol; 2022 May; 226(5):704.e1-704.e9. PubMed ID: 34954217
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of vaccination against oral HPV-16 infection in high school students in the city of Cali, Colombia.
    Castillo A; Osorio JC; Fernández A; Méndez F; Alarcón L; Arturo G; Herrero R; Bravo LE
    Papillomavirus Res; 2019 Jun; 7():112-117. PubMed ID: 30851448
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A single dose of quadrivalent human papillomavirus (HPV) vaccine is immunogenic and reduces HPV detection rates in young women in Mongolia, six years after vaccination.
    Batmunkh T; Dalmau MT; Munkhsaikhan ME; Khorolsuren T; Namjil N; Surenjav U; Toh ZQ; Licciardi PV; Russell FM; Garland SM; Mulholland K; von Mollendorf C
    Vaccine; 2020 Jun; 38(27):4316-4324. PubMed ID: 32387009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.